Physician profile
Patrick Howard Counts
NPI 1841814423
$3,428.53
in general payments reported to CMS, 2019-2025
23 companies · $1,932 in 2025
The $1,932 reported for 2025 was more than what 92% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $15.49 · 2023: $217 · 2024: $1,263 · 2025: $1,932.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,608 · Travel and Lodging: $805.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,608.28 |
| Travel and Lodging | $804.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $998.51 | 2024-2025 | Eterna, Proclaim |
| Curonix LLC | $628.90 | 2024-2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Medtronic, INC. | $389.87 | 2025 | Inceptiv, Synchromedii, Kyphon Express II Kyphopak Tray |
| Globus Medical, INC. | $326.68 | 2025 | Senza, Corridor |
| Foundation Fusion Solutions, LLC | $273.48 | 2025 | |
| Paratek Pharmaceuticals, INC. | $148.50 | 2023-2024 | Nuzyra |
| Tersera Therapeutics LLC | $145.35 | 2025 | Prialt |
| Insmed, INC. | $106.91 | 2023-2024 | Arikayce |
| Spinal Simplicity, LLC | $52.98 | 2024-2025 | Ha Minuteman G3-R |
| Ipsen Biopharmaceuticals, INC | $46.44 | 2025 | Dysport |
| Depuy Synthes Sales INC. | $40.89 | 2025 | Confidence Spinal Cement System |
| Baxter Healthcare | $38.03 | 2023-2024 | Hillrom - Vest System Model 105 Home Care |
| Boston Scientific Corporation | $31.94 | 2024 | |
| Spr Therapeutics, INC | $28.50 | 2025 | Sprint Pns System |
| Convatec INC. | $26.02 | 2024 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $22.66 | 2024 | Emgality |
| Si-Bone, INC. | $22.62 | 2025 | |
| Mml US, INC. | $19.12 | 2025 | Reactiv8 |
| Biotronik Nro, INC. | $18.63 | 2025 | Prospera |
| Astellas Pharma US INC | $18.36 | 2024 | Cresemba |
| Glaxosmithkline, LLC. | $15.49 | 2022 | |
| Abbvie INC. | $14.61 | 2025 | |
| Pfizer INC. | $14.04 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patrick Counts listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.